Metabolic-Fit / 100
LIV by WellNow review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
LIV by WellNow now advertises compounded semaglutide at $195 a month, including medication, supplies and unlimited virtual visits. Tirzepatide is not offered on the page.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
LIV by WellNow at a glance
- Semaglutide
- $195/mo (all-inclusive)
- Tirzepatide
- Not offered — compounded semaglutide only
- Coverage
- IL, IN, MI, NY, PA
- Brand-name
- Compounded only
How we scored LIV by WellNow
Every factor comes from LIV by WellNow's own published pricing, disclosures and oversight, and the six combine into the 47/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
LIV by WellNow now advertises compounded semaglutide at $195 a month, including medication, supplies and unlimited virtual visits. Tirzepatide is not offered on the page.
Before you sign up
What LIV by WellNow's public site and signup page show before you hand over any details.
Worth knowing
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $195 | Publicly advertised plan; see noteHomepage now states new low price $195/month, medication, supplies and unlimited virtual visits included. The separate Save $20/mo claim is not the standing headline. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what LIV by WellNow's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Backed by WellNow Urgent Care, an established regional healthcare brand
- Explicit, accurate on-page disclosure that compounded semaglutide isn't FDA-approved — an honesty plus
- Clear, disclosed eligibility criteria (BMI 30+, or 27+ with a named comorbid condition)
The caveats
- Compounded semaglutide only — no tirzepatide and no brand-name path
- Narrow 5-state footprint (IL, IN, MI, NY, PA)
- No insurance accepted
- No postpartum, breastfeeding or PCOS-specific guidance found
A regional service with one listed GLP-1
LIV by WellNow advertises compounded semaglutide at $195 monthly, including medication, injection supplies and unlimited virtual visits. Tirzepatide is not offered on its treatment page. That makes the first decision quite specific: whether the clinician-approved semaglutide program and regional service fit your needs. Someone seeking to continue a tirzepatide prescription should not assume that the same platform has an equivalent product simply because both medicines are commonly discussed together.
The $195 amount is the current advertised standing price, rather than the separate save-$20 message. Ask which supply and prescribed dose the quote covers, and whether delivery or any other service creates an additional charge. Medication and virtual visits are expressly listed; that does not automatically establish that every laboratory test or unrelated clinical request is included. A written order should make those boundaries understandable before the first payment.
WellNow's name does not erase location limits
The service is backed by WellNow Urgent Care, an established regional healthcare brand. That connection may be familiar to someone who has used its clinics, but familiarity does not establish the identity of the clinician managing a particular online prescription. Ask how the virtual team relates to local services, where medical questions go and whether an in-person evaluation can be arranged if the clinician considers one necessary.
LIV's listed footprint is Illinois, Indiana, Michigan, New York and Pennsylvania. That five-state availability is a hard practical distinction from providers advertising nationwide service. Confirm your treatment address, especially if you move or spend extended time elsewhere. Eligibility in one state should not be assumed to carry automatically to another, and a familiar urgent-care name outside the listed area does not itself establish access to this particular prescription program.
Explicit screening is useful, but not a personal clearance
LIV publishes eligibility criteria involving BMI and associated conditions. Those criteria help a prospective patient understand the program's intended population, without guaranteeing that someone meeting the numerical threshold will receive medication. The clinician still needs to review medical history, other treatment and the proposed prescription. An online screening result is therefore a starting point for assessment, not an instruction to begin or change a medicine independently.
Its public disclosure correctly distinguishes compounded semaglutide from an FDA-approved finished product. That is relevant information when comparing LIV with brand-name Wegovy or Ozempic access elsewhere. The same ingredient name does not make the preparations identical. Ask the prescriber about the formulation and dispensing pharmacy, and obtain instructions for the exact product. The published menu does not establish a brand-name GLP-1 route as an alternative within this plan.
Unlimited visits need a workable follow-up arrangement
Unlimited virtual visits may be valuable when questions arise between supplies, but the phrase does not establish immediate availability, a particular appointment duration or a guaranteed response time. Ask how to book, whether follow-up is scheduled proactively and how a medication concern is routed to the treating clinician. That practical access matters more than assuming every question can be resolved instantly because the number of visits is unlimited.
LIV does not accept insurance for the advertised program and does not publish specific postpartum, breastfeeding or PCOS guidance on its public site. Those limits should be discussed before choosing a recurring plan, along with cancellation deadlines and the treatment of medication already prepared. LIV is most relevant to a reader in its five-state area who wants its semaglutide-and-virtual-visit arrangement. Someone needing another molecule, a brand prescription or documented maternal specialty has a different requirement to establish before considering the price.
The bottom line for mothers
Best for: Mothers in IL, IN, MI, NY or PA who want one flat, all-inclusive price from a recognizable regional healthcare brand and are fine with compounded semaglutide only.
Alternatives to LIV by WellNow
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Bodybuilding Health+59
Metabolic-Fit / 100
Bodybuilding Health+ does the disclosure part better than most of this market and the branding part more loosely. It names four compounding pharmacies outright with phone numbers, and it names two lead physicians with their NPI numbers — both of whom check out as active MDs in the federal registry. Pricing is flat at every dose and public before any intake: $179 a month for compounded semaglutide and $209 for tirzepatide, dropping to about $142 and $175 only if you buy a bundle up front. The looser part is the name. The operator is Dynamo Group LLC of Boca Raton, not Bodybuilding.com, and the 'trusted by millions since 1999' line on the page is the licensor's heritage rather than the clinic's. It's compounded-only, so there's no FDA-approved Wegovy or Zepbound route, the bundle discounts come with no published refund terms, and a prominent '4.8 (200+ reviews)' badge sits above a Trustpilot widget whose rating we could not confirm.
- Visit bmiMD45
Metabolic-Fit / 100
A complete plan table and real nationwide coverage, undercut by a homepage that strikes the same product through from two different “regular” prices.
Providers like LIV by WellNow
Keep comparing LIV by WellNow
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
LIV by WellNow, answered
- How much does LIV by WellNow cost?
- LIV by WellNow now advertises compounded semaglutide at $195 a month, including medication, supplies and unlimited virtual visits. Tirzepatide is not offered on the page.
- Does LIV by WellNow offer tirzepatide or brand medication?
- No — it offers compounded semaglutide only. There's no tirzepatide option and no brand (Wegovy/Ozempic) pathway.
- Is LIV by WellNow's compounded semaglutide FDA-approved?
- No, and to its credit the site says so plainly: 'Compounded semaglutide is not approved or evaluated for safety, efficacy, or quality by FDA.' That's an honest disclosure many compounded sellers bury or omit.
Pricing, states and verification reflect LIV by WellNow's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.